Supplementary Table 4. Changes of Apolipoproteins at Week 40 (LOCF).

	Group	n	Baseline	Week 40 (LOCF)	% change	p
Apolipoprotein AI, mg/dL	Total	109	143.3±20.7	150.2±22.8	5.1±10.1	＜0.001
	K-924 LD	62	144.6±19.5	151.4±20.3	5.2±10.1	＜0.001
	K-924 HD	47	141.6±22.3	148.7±25.9	5.1±10.4	0.002
Apolipoprotein AII, mg/dL	Total	109	33.9±6.3	33.9±5.5	1.0±10.7	0.339
	K-924 LD	62	33.8±6.4	33.6±4.9	0.7±11.6	0.623
	K-924 HD	47	34.0±6.3	34.3±6.2	1.3±9.6	0.348
Apolipoprotein B, mg/dL	Total	109	96.7±18.7	77.5±16.6	-18.9±13.4	＜0.001
	K-924 LD	62	94.9±17.0	77.0±13.4	-18.1±11.5	＜0.001
	K-924 HD	47	99.0±20.8	78.2±20.1	-20.1±15.7	＜0.001
Apolipoprotein B48, mg/dL	Total	106	8.0±6.1	13.7±16.0	84.0±129.3	＜0.001
	K-924 LD	62	7.6±6.1	13.5±14.5	94.0±131.9	＜0.001
	K-924 HD	44	8.6±6.0	13.9±18.0	69.9±125.8	0.001
Apolipoprotein CII, mg/dL	Total	109	5.6±2.2	4.8±1.9	-12.7±20.2	＜0.001
	K-924 LD	62	5.4±2.2	4.7±1.8	-10.3±18.8	＜0.001
	K-924 HD	47	5.9±2.1	4.8±2.0	-15.9±21.7	＜0.001
Apolipoprotein CIII, mg/dL	Total	109	11.7±3.5	10.4±3.8	-10.0±19.8	＜0.001
	K-924 LD	62	11.4±3.6	10.0±3.1	-10.5±18.5	＜0.001
	K-924 HD	47	12.0±3.3	10.9±4.4	-9.4±21.6	0.005
Apolipoprotein E, mg/dL	Total	109	2.9±1.1	2.3±1.0	-16.8±23.4	＜0.001
	K-924 LD	62	2.8±1.1	2.3±1.0	-16.9±23.6	＜0.001
	K-924 HD	47	2.9±1.0	2.4±1.1	-16.7±23.5	＜0.001

Data are presented as the mean±standard deviation. P values were calculated using a one-sample t-test.

Abbreviations: LOCF, last observation carried forward.